Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2017 Feb 1;21(1):27-30.
doi: 10.5935/1518-0557.20170008.

Low concentration of hyaluronidase for oocyte denudation can improve fertilization rates and embryo quality

Affiliations
Randomized Controlled Trial

Low concentration of hyaluronidase for oocyte denudation can improve fertilization rates and embryo quality

Bernardo R L de Moura et al. JBRA Assist Reprod. .

Abstract

Objective: Hyaluronidase enzyme is an extremely important factor for the process of oocyte denudation, but little is known about its negative effects.

Methods: This prospective randomized study analyzed the results of using different concentrations of hyaluronidase (Diluted: 8IU/mL and Normal: 80IU/mL) used for denudation of sibling-oocytes for 22 women undergoing treatment for assisted reproduction by ICSI. A total of 192 oocytes were injected, being 104 for group I (diluted) and 88 for group II (normal). We analyzed fertilization rate, cleavage, embryo quality at 48 and 72 hours and number of transferred embryos in each group.

Results: The diluted enzyme group showed better results in fertilization rates (92.3% vs. 80.6%), mean cleavage (4.18 ± 2.57 vs. 3.09 ± 1.90), in 48-hour embryos A and A + B (60.9% vs. 44.1% and 90.2% vs. 82.3%) and at 72 hours (45.6% vs. 36.8% and 77.1% vs 66.2%), and number of embryos selected for transfer (61.8% vs. 38.1%). The overall pregnancy rate was 59.1%.

Conclusion: This study demonstrates that the use of 8 IU/mL of hyaluronidase, according to the following protocol, is beneficial and can be successfully used for oocyte denudation, and it is also economically advantageous to the laboratory.

Keywords: Hyaluronidase; ICSI; cumulus- oocyte complex; oocyte denudation.

PubMed Disclaimer

References

    1. Abdelmassih R, Sollia S, Moretto M, Acosta AA. Female age is an important parameter to predict treatment outcome in intracytoplasmic sperm injection. Fertil Steril. 1996;65:573–577. http://dx.doi.org/10.1016/S0015-0282(16)58156-4 - DOI - PubMed
    1. Abramczuk JW, Lopata A. Resistance of human follicular oocytes to parthenogenetic activation: DNA distribution and content in oocytes maintained in vitro. Hum Reprod. 1990;5:578–581. http://dx.doi.org/10.1093/oxfordjournals.humrep.a137148 - DOI - PubMed
    1. De Vos A, Van Landuyt L, Van Ranst H, Vandermonde A, D'Haese V, Sterckx J, Haentjens P, Devroey P, Van der Elst J. Randomized sibling-oocyte study using recombinant human hyaluronidase versus bovine derived Sigma hyaluronidase in ICSI patients. Hum Reprod. 2008;23:1815–1819. http://dx.doi.org/10.1093/humrep/den212 - DOI - PubMed
    1. Dozortsev D, Nagy P, Abdelmassih S, Oliveira F, Brasil A, Abdelmassih V, Diamond M, Abdelmassih R. The optimal time for intracytoplasmic sperm injection in the human is from 37 to 41 hours after administration of human chorionic gonadotropin. Fertil Steril. 2004;82:1492–1496. http://dx.doi.org/10.1016/j.fertnstert.2004.09.002 - DOI - PubMed
    1. Ebner T, Moser M, Sommergruber M, Shebl O, Tews G. Incomplete denudation of oocytes prior to ICSI enhances embryo quality and blastocyst development. Hum Reprod. 2006;21:2972–2977. http://dx.doi.org/10.1093/humrep/del272 - DOI - PubMed

Publication types

Substances

LinkOut - more resources